Fig. 4From: Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patientsThe Kaplan–Meier survival curve for different variables, including local therapies (A), genders (B), Karnofsky performance scale (KPS) (C), and different oligoprogression types (D) in patients with NSCLC central nervous system oligoprogressionBack to article page